Skip to main content
ASHI 50th Annual Meeting Mobile App Main banner
Back

Shi-Yuan (Tina) Meng, PhD

Thermo Fisher Scientific

Shi-Yuan, also known as Tina, Meng obtained a bachelor’s degree in Agricultural Chemistry from National Taiwan University before continuing post-graduate studies at Rice University where she received her PhD degree in Biochemistry and Cell Biology. She then joined the Process Development at Amgen improving microbial expression systems and optimizing fermentation processes to produce human therapeutics. In time, she extended expertise into viral and eukaryotic expression systems and joined Discovery Technologies in R&D that generated biological reagents such as antigens, antibodies, and cell lines for all stages of human therapeutics development in disease areas including Inflammation, Oncology, Metabolism, and Neuroscience. Of interest particularly were membrane proteins and their functional monoclonal antibodies. After 22 years at Amgen and a stint at a start-up biotech, she joined Thermo Fisher Scientific in 2015 managing a group of scientists devoted to transplant diagnostics by providing critical reagents such as antigens, antibodies, DNA, and cells. Her group was also instrumental in supplying antigens in quick turnaround in responding to COVID-19 pandemic. More recently, she and colleagues began to contemplate the next generation of HLA antibody detection considering the clinical needs for a broader coverage and a higher resolution at the serological level.

Disclosure information not submitted.

Presentation(s):